Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Science (New York, N.Y.)|September 16, 2021
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesisEdoardo Del Poggetto, I-Lin Ho, Chiara Balestrieri, et al.
Cancer Discovery|August 21, 2020
BI-3406, a Potent and Selective SOS1-KRAS Interaction Inhibitor, Is Effective in KRAS-Driven Cancers through Combined MEK InhibitionMarco H Hofmann, Michael Gmachl, Juergen Ramharter, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRAS G12D inhibition in pancreatic ductal adenocarcinomaKathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li, et al.
Nature|March 5, 2025
Evolutionary fingerprints of epithelial-to-mesenchymal transitionLuigi Perelli, Li Zhang, Sarah Mangiameli, et al.
JCO Clinical Cancer Informatics|August 9, 2022
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data SetStephanie T Schmidt, Neal Akhave, Ryan E Knightly, et al.
Cancer Cell|February 13, 2019
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid TumorsAlessandro Carugo, Rosalba Minelli, Luigi Sapio, et al.
Gastroenterology|March 22, 2021
Sequential Administration of XPO1 and ATR Inhibitors Enhances Therapeutic Response in TP53-mutated Colorectal CancerAkira Inoue, Frederick S Robinson, Rosalba Minelli, et al.
Nature|March 29, 2019
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancerWantong Yao, Johnathon L Rose, Wei Wang, et al.
The EMBO Journal|July 11, 2026
CDK8 remodels the tumor microenvironment and promotes resistance to KRASG12D inhibitors and daraxonrasib in PDACKathleen M McAndrews, Krishnan K Mahadevan, Bingrui Li, et al.
Pageof 8